Last reviewed · How we verify
Cardiovascular risk
Approved treatments
- Tryvio · Idorsia
Tryvio works by blocking the action of endothelin, a protein that constricts blood vessels and increases blood pressure.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Cardiovascular risk patent landscape — cliff calendar, originator estates, attackable patents
- Cardiovascular risk treatment landscape brief
- Cardiovascular risk treatment updates RSS
Frequently asked questions about Cardiovascular risk
What drugs treat Cardiovascular risk?
Tracked treatments include Tryvio.
What is the treatment for Cardiovascular risk?
Standard treatment for Cardiovascular risk includes Tryvio. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Cardiovascular risk patent cliff · Cardiovascular risk CI report
- Treatment: Tryvio · Idorsia
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing